InfoPack
Recent JCP Articles on InfoPack
Original Research
Long-Term Outcomes of IV Ketamine and IN Esketamine in Treatment-Refractory Depression
July 30, 2025
The study results suggest that patients with treatment-resistant depression who are on maintenance treatment require less frequent treatments with IV ketamine compared to IN esketamine.
Original Research
Early Change in Depressive Symptom Severity with Naltrexone-Bupropion Combination and Its Association with Reduction in Methamphetamine Use: ADAPT-2 Trial
July 30, 2025
Improvement in depression accounted for approximately 25% of the treatment effect of naltrexone-bupropion on methamphetamine treatment response.
Recent PCC Articles on InfoPack
Rounds in the General Hospital
Managing Psychotropic Medication–Induced Priapism
July 31, 2025
A 30-year-old man with schizoaffective disorder presented to the ED with a prolonged, painful erection of spontaneous onset. His current medications included long-acting injectable paliperidone palmitate, valproic acid, and...